Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
暂无分享,去创建一个
[1] R. Weiss,et al. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.
[2] D. Ferguson,et al. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. , 1990, Journal of the American College of Cardiology.
[3] E. Vizi,et al. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. , 1994, Cardiovascular research.
[4] J S Floras,et al. Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure. , 2001, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[5] J. Floras,et al. Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle. , 1995, Circulation.
[6] M. Thames,et al. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. , 1996, Journal of the American College of Cardiology.
[7] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[8] M. Naughton,et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. , 1995, American journal of respiratory and critical care medicine.
[9] BengtRundqvist,et al. Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure , 1997 .
[10] K. Umeno,et al. Respiratory Modulation of Muscle Sympathetic Nerve Activity in Patients With Chronic Heart Failure , 2001, Circulation.
[11] W. Dupont,et al. Ethnic and Genetic Determinants of Cardiovascular Response to the Selective &agr;2-Adrenoceptor Agonist Dexmedetomidine , 2008, Hypertension.
[12] D. Ferguson,et al. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct micronenrographic recordings , 1990 .
[13] M. Piepoli,et al. Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. , 1996, Clinical science.
[14] S. Ando,et al. Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea , 2005, Hypertension.
[15] G. Tomlinson,et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. , 2007, Journal of the American College of Cardiology.
[16] C. Liang,et al. Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. , 1994, The American journal of physiology.
[17] N. de Luca,et al. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. , 1991, The Journal of clinical investigation.
[18] R. Weiss,et al. Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure , 2006, Circulation Research.
[19] M. Emdin,et al. Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. , 2008, Clinical science.
[20] Lie Gao,et al. Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase , 2004, Circulation research.
[21] J. Floras,et al. Respiratory correlates of muscle sympathetic nerve activity in heart failure. , 1998, Clinical science.
[22] A. Logan,et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. , 2003, Chest.
[23] J. Floras,et al. Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure. , 2007, Journal of cardiac failure.
[24] J. Floras,et al. Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. , 2001, American journal of physiology. Heart and circulatory physiology.
[25] J. Skatrud,et al. Exposure to hypoxia produces long-lasting sympathetic activation in humans. , 2001, Journal of applied physiology.
[26] G. Pickering,et al. Reflex Regulation of Arterial Pressure during Sleep in Man: A Quantitative Method of Assessing Baroreflex Sensitivity , 1969, Circulation research.
[27] H. Middlekauff,et al. Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.
[28] J S Floras,et al. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. , 1997, The American journal of physiology.
[29] W. White,et al. Ambulatory Monitoring of Blood Pressure , 2001 .
[30] M. Esler,et al. Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure , 2002, Circulation.
[31] E. Potter,et al. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat. , 1999, Journal of the autonomic nervous system.
[32] M. Esler,et al. beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. , 2001, Lancet.
[33] J S Floras,et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. , 1999, American journal of respiratory and critical care medicine.
[34] G Mancia,et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.
[35] J. Brown,et al. Further characterization of the presynaptic alpha-1 receptor modulating [3H]ACh release from rat atria. , 1986, The Journal of pharmacology and experimental therapeutics.
[36] S. Ando,et al. Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine. , 1998, The Journal of clinical investigation.
[37] N. Montano,et al. Altered cardiovascular variability in obstructive sleep apnea. , 1998, Circulation.
[38] J. Dempsey,et al. Carotid Chemoreceptor Modulation of Regional Blood Flow Distribution During Exercise in Health and Chronic Heart Failure , 2007, Circulation research.
[39] P. Sleight,et al. Scientific Foundations of Cardiology , 1985 .
[40] C. Liang,et al. Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure. , 2000, American journal of physiology. Heart and circulatory physiology.
[41] P. Picton,et al. Vagal heart rate responses to chronic beta‐blockade in human heart failure relate to cardiac norepinephrine spillover , 2005, European journal of heart failure.
[42] G. Newton,et al. Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure. , 1996, Circulation.
[43] M. Bristow. Changes in myocardial and vascular receptors in heart failure. , 1993, Journal of the American College of Cardiology.
[44] A. Quyyumi,et al. Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.
[45] Robin M McAllen,et al. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure , 2009, Proceedings of the National Academy of Sciences.
[46] I. Zucker,et al. Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs. , 1996, Journal of applied physiology.
[47] M. Böhm,et al. Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.
[48] M. Thames,et al. Effect of chronic myocardial infarction on vagal cardiopulmonary baroreflex. , 1989, Circulation research.
[49] J. Floras. Arterial Baroreceptor and Cardiopulmonary Reflex Control of Sympathetic Outflow in Human Heart Failure , 2001, Annals of the New York Academy of Sciences.
[50] M. Esler,et al. β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure , 2001, The Lancet.
[51] G. Eisenhofer,et al. Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart. , 1997, American journal of physiology. Heart and circulatory physiology.
[52] A. Mark,et al. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. , 1996, Circulation.
[53] S. Ando,et al. Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. , 2003 .
[54] I. Zucker,et al. Reduced NO enhances the central gain of cardiac sympathetic afferent reflex in dogs with heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.
[55] H. Middlekauff,et al. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. , 2003, Journal of the American College of Cardiology.
[56] M. Pfeffer,et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. , 2002, Journal of the American College of Cardiology.
[57] S. Yusuf,et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. , 1993, Journal of the American College of Cardiology.
[58] G. Wallukat,et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. , 1994, Circulation.
[59] W. Wang,et al. Volume expansion potentiates cardiac sympathetic afferent reflex in dogs. , 2001, American journal of physiology. Heart and circulatory physiology.
[60] G. Jennings,et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. , 1994, Journal of the American College of Cardiology.
[61] S. Ando,et al. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. , 1999, European heart journal.
[62] W. Wang,et al. Cardiac sympathetic afferent sensitivity is enhanced in heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.
[63] T. Young,et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. , 2006, Archives of internal medicine.
[64] J. Floras. Chapter 16 – Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure , 2011 .
[65] D P Zipes,et al. Influence of Myocardial Ischemia and Infarction on Autonomic Innervation of Heart , 1990, Circulation.
[66] M. Esler,et al. Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity , 2003, Circulation.
[67] F. Leenen. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. , 2007, Circulation research.
[68] G. Tomlinson,et al. Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure: A Post Hoc Analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP) , 2007, Circulation.
[69] Daly Pa,et al. Myocardial catecholamines and the pathophysiology of heart failure. , 1990 .
[70] G. Jennings,et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.
[71] J. Parker,et al. Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure , 2004, Circulation.
[72] A. Vallbo,et al. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. , 2004, Journal of applied physiology.
[73] M. Lab,et al. Contribution to heart rate variability by mechanoelectric feedback. Stretch of the sinoatrial node reduces heart rate variability. , 1996, Circulation.
[74] R. Page,et al. Biventricular Pacing Decreases Sympathetic Activity Compared With Right Ventricular Pacing in Patients With Depressed Ejection Fraction , 2000, Circulation.
[75] V. Somers,et al. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. , 1999, Circulation.
[76] Z. Topor,et al. Dynamic ventilatory response to CO(2) in congestive heart failure patients with and without central sleep apnea. , 2001, Journal of applied physiology.
[77] H. Dajani,et al. Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea , 2000, Journal of hypertension.
[78] P. Ernsberger,et al. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. , 2003, American journal of physiology. Heart and circulatory physiology.
[79] Roberto Maestri,et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. , 2009, Journal of the American College of Cardiology.
[80] A. Dart,et al. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. , 1998, Journal of the American College of Cardiology.
[81] G. Breithardt,et al. Ischemic versus idiopathic cardiomyopathy: differing neurohumoral profiles despite comparable peak oxygen uptake. , 1997, International journal of cardiology.
[82] J. Floras,et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. , 2005, Journal of the American College of Cardiology.
[83] P. Ponikowski,et al. Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. , 1997, European heart journal.
[84] H. Figulla,et al. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[85] S. Kardia,et al. Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .
[86] J. Floras,et al. Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure. , 2000, Journal of cardiovascular pharmacology.
[87] G. Mancia,et al. Sympathetic Response to Ventricular Extrasystolic Beats in Hypertension and Heart Failure , 2002, Hypertension.
[88] J. Floras. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. , 1993, Journal of the American College of Cardiology.
[89] J S Floras,et al. Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure. , 1997, Circulation.
[90] D. Paterson,et al. Should we still use nitrovasodilators to test baroreflex sensitivity? , 2000, Journal of hypertension.
[91] S. Ando,et al. Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure. , 1999, Circulation.
[92] Yanfeng Ding,et al. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. , 2007, Hypertension.
[93] T Douglas Bradley,et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. , 2003, The New England journal of medicine.
[94] R. Weiss,et al. Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure? , 2008, Hypertension.
[95] J. J. Smith,et al. Effects of aging on baroreflex regulation of sympathetic activity in humans. , 1992, The American journal of physiology.
[96] D. Ferguson,et al. Effects of heart failure on baroreflex control of sympathetic neural activity. , 1992, The American journal of cardiology.
[97] Giuseppe Mancia,et al. Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients , 2003, Hypertension.
[98] W. Hundley,et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.
[99] M. Esler,et al. Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure , 2001, Circulation.
[100] S. Goldsmith,et al. Angiotensin II and sympathetic activity in patients with congestive heart failure. , 1993, Journal of the American College of Cardiology.
[101] A. Malliani,et al. Emerging Excitatory Role of Cardiovascular Sympathetic Afferents in Pathophysiological Conditions , 2002, Hypertension.
[102] M. Guazzi,et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. , 1994, The American journal of medicine.
[103] S. Rucki. [Ambulatory monitoring of blood pressure--focus on childhood]. , 2000, Casopis lekaru ceskych.
[104] I. Zucker. Brain angiotensin II: new insights into its role in sympathetic regulation. , 2002, Circulation research.
[105] M. Esler,et al. Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. , 2001, Journal of the American College of Cardiology.
[106] J. Parker,et al. Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. , 1999, Circulation.
[107] G. Mancia,et al. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. , 2001, Clinical science.
[108] C. Kappagoda,et al. The rapidly adapting receptors in mammalian airways and their responses to changes in extravascular fluid volume , 2006, Experimental physiology.
[109] M. Esler,et al. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. , 2004, Journal of the American College of Cardiology.
[110] G. Grassi,et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.
[111] E. Irwin,et al. Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure , 2007, Hypertension.
[112] G. Lambert,et al. Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure * , 2005, European journal of heart failure.
[113] T. Lüscher,et al. Nasal oxygen and muscle sympathetic nerve activity in heart failure. , 2003, Chest.
[114] W. Wang,et al. Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs. , 1999, The American journal of physiology.
[115] S. Ando,et al. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. , 2001, Chest.
[116] K J Osterziel,et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1996, Circulation.
[117] F. Abboud,et al. Sympathetic-nerve activity during sleep in normal subjects. , 1993, The New England journal of medicine.
[118] J. Floras. The "unsympathetic" nervous system of heart failure. , 2002, Circulation.
[119] P. Linkowski,et al. Effects of wake and sleep stages on the 24-h autonomic control of blood pressure and heart rate in recumbent men. , 1994, The American journal of physiology.
[120] J. Floras,et al. Nonselective Versus Selective &bgr;-Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity , 2001, Circulation.
[121] J. Floras,et al. Effects of forearm venous occlusion on peroneal muscle sympathetic nerve activity in healthy subjects. , 1995, The American journal of cardiology.
[122] F. Abboud,et al. Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.
[123] W. Klein,et al. Routine lipid profile in patients with and without restenosis after percutaneous transluminal coronary angioplasty. , 1992, The American journal of cardiology.
[124] I. Reid. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. , 1992, The American journal of physiology.
[125] T. LeJemtel,et al. Heart Rate Variability and Diastolic Heart Failure , 2004, Pacing and clinical electrophysiology : PACE.
[126] T. Lohmeier,et al. Influence of Prolonged Baroreflex Activation on Arterial Pressure in Angiotensin Hypertension , 2005, Hypertension.
[127] J. Floras,et al. Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.
[128] R. Neubig,et al. Phagocyte-derived catecholamines enhance acute inflammatory injury , 2007, Nature.
[129] I. Zucker,et al. Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. , 1997, The American journal of physiology.
[130] M. Dibner-Dunlap. Arterial or cardiopulmonary baroreflex control of sympathetic nerve activity in heart failure? , 1992, The American journal of cardiology.
[131] T. Nozawa,et al. Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure. , 2004, Journal of cardiac failure.
[132] I. Zucker,et al. Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure , 2006, Hypertension.
[133] S. Javaheri. Pembrey's dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. , 2003, Chest.
[134] A. Gebert,et al. Luminal antigens access late endosomes of intestinal epithelial cells enriched in MHC I and MHC II molecules: in vivo study in Crohn's ileitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[135] D. McCloskey,et al. Inhibition by angiotensin II of baroreceptor‐evoked activity in cardiac vagal efferent nerves in the dog. , 1979, The Journal of physiology.
[136] J. Floras,et al. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. , 2000, Circulation.
[137] J. McMurray,et al. Neurohumoral pathways in heart failure with preserved systolic function. , 2005, Progress in cardiovascular diseases.
[138] D L Eckberg,et al. Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.
[139] L. Graham,et al. Time Course of Sympathetic Neural Hyperactivity After Uncomplicated Acute Myocardial Infarction , 2002, Circulation.
[140] P. Ponikowski,et al. Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure , 2001, Circulation.
[141] Francois M. Abboud,et al. Interaction of Cardiovascular Reflexes in Circulatory Control , 2011 .
[142] M. N. Levy,et al. Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. , 1980, The American journal of physiology.
[143] G. Fonarow,et al. Muscle mechanoreceptor sensitivity in heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.
[144] C. May,et al. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. , 2007, American journal of physiology. Heart and circulatory physiology.
[145] G. Jennings,et al. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. , 1995, Circulation.
[146] R. Wenzel. Diuretics in heart failure. , 1986, Lancet.
[147] P. Binkley,et al. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. , 1991, Journal of the American College of Cardiology.